Velcheti, V., Hu, X., Piperdi, B., & Burke, T. (2021). Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices. Sci Rep.
Citação norma ChicagoVelcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, and Thomas Burke. "Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC At US Oncology Practices." Sci Rep 2021.
Citação norma MLAVelcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, and Thomas Burke. "Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC At US Oncology Practices." Sci Rep 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.